Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06948110 · ClinicalTrials.gov registry record
Deciphering the Genetic Architecture of Autoimmune Diseases
A clinical trial of Autoimmune Diseases, sponsored by National Human Genome Research Institute (NHGRI).
- Recruiting
- Registry status
- 300
- Enrollment target
- 2
- Study locations
NCT06948110 is a study of Autoimmune Diseases that is actively recruiting participants, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 300 participants, below the 966-participant average among 25 other Autoimmune Diseases trials with a reported enrollment target (69% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06948110, a study of Autoimmune Diseases, is actively recruiting participants, sponsored by National Human Genome Research Institute (NHGRI).
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
Background: Autoimmune diseases can be caused by genes people inherit from their parents. The gene changes that cause these diseases have been well studied in people with European and Asian ancestors. But some diseases behave differently in people who are native to North and South America. Researchers want to know more about the gene changes and other factors that may cause autoimmune diseases among these people. This project will be based in Peru. Objective: To study how gene changes can lead to autoimmune diseases in people native to Peru. Eligibility: People aged 18 years and older with an autoimmune disease. These may include systemic lupus erythematosus; Sjogren disease; scleroderma; rheumatoid arthritis; seronegative spondylo-arthropathies; and systemic vasculitis. Family members and healthy volunteers are also needed. Design: Participants will have 2 clinic visits; these will be 2 weeks apart. The clinics will be in Lima, Iquitos, and other sites in Peru. Visit 1: Participants will have a physical exam. They will answer questions about their health risks and habits. They will provide blood and urine samples. Visit 2: Participants will provide a second blood sample and a stool sample. They will talk about the results of their first clinical exam with researchers. The cost of travel to and from the clinics will be provided. Participants will get $30 per visit and a snack.
Conditions Studied
Study Locations (2)
Maryland
- National Human Genome Research Institute (NHGRI) - Bethesda
Other
- Amazon Rainforest - Lima
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2026-03-26 |
| Est. Completion | 2030-04-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06948110
The ClinicalTrials.gov registry entry for NCT06948110 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 966-participant average among 25 other Autoimmune Diseases trials with a reported enrollment target (69% lower). The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Autoimmune Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT06948110 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Other.
Frequently Asked Questions
What is clinical trial NCT06948110 about?
NCT06948110 is a clinical study titled "Deciphering the Genetic Architecture of Autoimmune Diseases". Background: Autoimmune diseases can be caused by genes people inherit from their parents. The gene changes that cause these diseases have been well studied in people with European and Asian ancestors. But some diseases behave differently in people who are native to North and South America. Research...
What is the current status of trial NCT06948110?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2026-03-26. Estimated completion is 2030-04-22.
What conditions does trial NCT06948110 study?
This clinical trial studies the following conditions: Autoimmune Diseases.
Who is sponsoring clinical trial NCT06948110?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06948110 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autoimmune Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rheumatology Diet Study
RECRUITING
-
Collection and Distribution of Biospecimens for Novel Research Uses
RECRUITING
-
Ovarian Tissue Cryopreservation for Fertility Preservation
RECRUITING
-
Maternal Autoimmune Disease Research Alliance (MADRA) Registry
RECRUITING
-
X-linked Moesin Associated Immunodeficiency
RECRUITING
-
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.